NASDAQ:VTVT
vTv Therapeutics Inc.
vTv Therapeutics Inc.'s revenue fell 100.0% in fiscal 2025 to $0.Summary generated from vTv Therapeutics Inc.'s SEC filings. Latest annual report filed Mar 10, 2026.
Key statistics
Fiscal 2025 from SEC filings. MethodologyRevenue (FY25)$0
Revenue growth−100.0%
Revenue, 5-yr CAGRn/a
Gross marginn/a
Operating marginn/a
Net marginn/a
ROICn/a
Return on equity−70.4%
Debt / equityn/a
Free cash flown/a
FCF marginn/a
Share count changen/a
Financials
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 4 | 2 | 0 | 1 | 0 |
| Operating income | −22 | −23 | −26 | −24 | −33 |
| Net income | −13 | −19 | −20 | −18 | −27 |
| Free cash flow | −19 | −16 | −19 | −25 | n/a |
Recent filings
- 8-KAmendment to articles or bylaws
Oct 6, 2026 - 10-QQuarterly report for the period ended Jun 30, 2026
Aug 6, 2026 - 8-KResults of operations and financial condition
Aug 6, 2026 - 4Insider transaction report
Jun 29, 2026 - 8-KResults of a shareholder vote
Jun 29, 2026 - 4Insider transaction report
Jun 29, 2026 - 8-KOther events
May 13, 2026 - 10-QQuarterly report for the period ended Mar 31, 2026
May 13, 2026